Menu
Back to Journals » OncoTargets and Therapy » Volume 6
Focus on treatment of lung carcinoid tumor
Authors Noel-Savina E, Descourt R
Received 2 July 2013
Accepted for publication 22 September 2013
Published 25 October 2013 Volume 2013:6 Pages 1533—1537
DOI https://doi.org/10.2147/OTT.S32464
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 5
Elise Noel-Savina,1 Renaud Descourt2
1Pulmonary Service, 2Thoracic Oncology Service, Hospital de la Cavale Blanche, CHU – Brest, Brest, France
Abstract: Bronchial typical carcinoid tumors are neuroendocrine bronchopulmonary tumors with a low-grade malignancy, and an atypical carcinoid is an intermediate form of these tumors. There is a lack of knowledge on the optimal treatment for these tumors. The surgical treatment of choice consists of a lobectomy supplemented by dissection. The benefit of chemotherapy and radiotherapy is unclear. Targeted therapy could be used in this condition, but there is a lack of research recommending it.
Keywords: carcinoid tumor, neuroendocrine tumor, bronchopulmonary tumor, treatment
© 2013 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.